Literature DB >> 32061909

Novel nortriterpenoids with new skeletons and limonoids from the fruits of Evodia rutaecarpa and their bioactivities.

Yu-Sheng Shi1, Hong-Min Xia2, Chuan-Hai Wu3, Chun-Bin Li1, Chen-Chen Duan1, Chang Che1, Xue-Jing Zhang1, Hao-Tian Li1, Yan Zhang4, Xu-Fu Zhang5.   

Abstract

Two novel nortriterpenoids together with 7 known compounds were isolated from the fruits of Evodia rutaecarpa. The structures of the new compounds were elucidated by spectroscopic analysis, X-ray, and electronic circular dichroism (ECD) calculations. Compound 1 is the first example of triterpenoid with a 27 (17 → 12)-abeo-five-ring skeleton. In turn, compound 2 possesses a unique C/D/E linear fused ring system and a methyl on C-21. Plausible biogenetic pathway for the new compounds 1 and 2 are also proposed. Compound 1 exhibited significantly antitumor activity against A549 and LoVo cells with IC50 values of 2.0 μM and 1.9 μM, respectively. Colony formation inhibition, cell cycle arrest and cell apoptosis of compound 1 were also evaluated. Compound 2, 6, 7 and 9 showed potent neuroprotective activities against serum-deprivation induced P12 cell damage.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Antitumor activity; Evodia rutaecarpa; Limonoid; Neuroprotective activity; Nortriterpenoid

Mesh:

Substances:

Year:  2020        PMID: 32061909     DOI: 10.1016/j.fitote.2020.104503

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  2 in total

1.  Limonin Isolated From Pomelo Seed Antagonizes Aβ25-35-Mediated Neuron Injury via PI3K/AKT Signaling Pathway by Regulating Cell Apoptosis.

Authors:  Yuanxin Qiu; Jingxian Yang; Lukai Ma; Mingyue Song; Guo Liu
Journal:  Front Nutr       Date:  2022-05-12

2.  Integrated serum pharmacochemistry and investigation of the anti-gastric ulcer effect of Zuojin pill in rats induced by ethanol.

Authors:  Jiaying Zhang; Yi Yin; Qianqian Xu; Xiaoqing Che; Chen Yu; Yan Ren; Dongsheng Li; Juanjuan Zhao
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.